UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016338
Receipt number R000018959
Scientific Title Evaluation of right ventricle and small vascular disease by using FDG-PET and BMIPP analogue imaging in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Date of disclosure of the study information 2015/02/01
Last modified on 2015/01/26 11:10:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of right ventricle and small vascular disease by using FDG-PET and BMIPP analogue imaging in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Acronym

vascular disease by using FDG-PET and BMIPP analogue imaging in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Scientific Title

Evaluation of right ventricle and small vascular disease by using FDG-PET and BMIPP analogue imaging in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Scientific Title:Acronym

vascular disease by using FDG-PET and BMIPP analogue imaging in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Region

Japan


Condition

Condition

pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Mitochondrial remodeling of right venticle myocytes and pulmonary vascular cells in patients with PAH and CTEPH

Basic objectives2

Others

Basic objectives -Others

Evaluation of small vasular alterations in CTEPH

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

An accumulation of glucose and fatty acid in right ventricle and vasculature

Key secondary outcomes

Evaluation of small vascular remodeling in CTEPH and a correlation between glucose and fatty acid accumulation and pulmonary hemodynamics


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

FDG-PET and BMIPP analogue imaging

Interventions/Control_2

lung biopsy in CTEPH patients

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)regardless of age or sex
2)mPAP>25mmHg in RHC
3)CTEPH who will undergo a PEA operation
4)patients with a written informed consent form

Key exclusion criteria

1)patients who are supposed to be unsuitable for this study by a study director

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Seiichiro Sakao

Organization

Graduate School of Medicine, Chiba University

Division name

Department of Respirology (B2)

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba, Japan

TEL

043-222-7171

Email

sakaos@faculty.chiba-u.jp


Public contact

Name of contact person

1st name
Middle name
Last name Seiichiro Sakao

Organization

Graduate School of Medicine, Chiba University

Division name

Department of Respirology (B2)

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba, Japan

TEL

043-222-7171

Homepage URL


Email

sakaos@faculty.chiba-u.jp


Sponsor or person

Institute

Department of Respirology (B2),Graduate School of Medicine, Chiba University

Institute

Department

Personal name



Funding Source

Organization

Money of authorized accounting of Department of Respirology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2011 Year 09 Month 28 Day

Date of IRB


Anticipated trial start date

2011 Year 10 Month 27 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 01 Month 26 Day

Last modified on

2015 Year 01 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018959


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name